These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20484471)

  • 1. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression.
    Sørensen K; Mouritsen A; Mogensen SS; Aksglaede L; Juul A
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3736-44. PubMed ID: 20484471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
    Sørensen K; Andersson AM; Skakkebaek NE; Juul A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IGF1 and insulin levels in girls with normal and precocious puberty.
    Sørensen K; Aksglaede L; Petersen JH; Andersson AM; Juul A
    Eur J Endocrinol; 2012 May; 166(5):903-10. PubMed ID: 22379117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.
    Potau N; Williams R; Ong K; Sánchez-Ufarte C; de Zegher F; Ibáñez L; Dunger D
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):756-62. PubMed ID: 14974918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
    Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
    Ibáñez L; Ong K; de Zegher F; Marcos MV; del Rio L; Dunger DB
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):372-9. PubMed ID: 12608944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10-20-year longitudinal cohort study in southern Thailand.
    Satitpatanapan P; Jaruratanasirikul S; Sriplung H
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):933-940. PubMed ID: 32623380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
    Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
    Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?
    Arslanian S; Suprasongsin C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1058-62. PubMed ID: 8772576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
    Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.
    Ibáñez L; Potau N; Chacon P; Pascual C; Carrascosa A
    Diabetologia; 1998 Sep; 41(9):1057-63. PubMed ID: 9754824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
    Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
    J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection.
    Demirbilek H; Alikasifoglu A; Gonc NE; Ozon A; Kandemir N
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):126-30. PubMed ID: 21790701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
    Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2008 May; 93(5):1841-5. PubMed ID: 18319306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin levels are not associated with obesity in central precocious puberty.
    Zurita-Cruz JN; Medina-Bravo P; Manuel-Apolinar L; Damasio-Santana L; Wakida-Kusunoki G; Padilla-Rojas M; Maldonado-Rivera C; Gutierrez-Gonzalez A; Nishimura-Meguro E; Garrido-Magaña E; Rivera-Hernández AJ; Villasís-Keever MA
    Peptides; 2018 Nov; 109():9-13. PubMed ID: 30273692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.